Try our Advanced Search for more refined results

Deals Rumor Mill: Valeant, Shell, PT Pertamina

By Benjamin Horney (October 8, 2014, 5:55 PM EDT) -- Valeant Pharmaceuticals Inc. and Pershing Square Capital Management still intend to pursue Botox maker Allergan Inc., and could increase their original $53 billion takeover offer to nearly $60 billion, according to a Tuesday report from the New York Times. The pursuit of Allergan has been ongoing for months, even spilling into the courts recently when Allergan sued to block activist investor Bill Ackman from participating in a shareholder vote on a board overhaul. The potential new offer could be for up to $191 a share, $15 per share more than the previous offer, the report said....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!